Methylated circulating tumor DNA in blood: power in cancer prognosis and response

Circulating tumor DNA (ctDNA) in the plasma or serum of cancer patients provides an opportunity for non-invasive sampling of tumor DNA. This ‘liquid biopsy’ allows for interrogations of DNA such as quantity, chromosomal alterations, sequence mutations and epigenetic changes, and can be used to guide...

Descripción completa

Detalles Bibliográficos
Autores principales: Warton, Kristina, Mahon, Kate L, Samimi, Goli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737995/
https://www.ncbi.nlm.nih.gov/pubmed/26764421
http://dx.doi.org/10.1530/ERC-15-0369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737995/
https://www.ncbi.nlm.nih.gov/pubmed/26764421
http://dx.doi.org/10.1530/ERC-15-0369

Ejemplares similares